Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Mallard Acquisition (MACUU)
MingZhu Logistics Holdings (YGMZ)
Good Works Acquisition (GWACU)
Bull Horn Holdings (BHSEU)
Decarbonization Plus Acquistion (DCRBU)
Horizon Acquisition II (HZON.U)
Helix Acquisition (HLXA)
Datto Holding Corp. (MSP)
McAfee Corp. (MCFE)
Guild Holdings Company (GHLD)
Abcam plc (ABCM)
Foghorn Therapeutics Inc. (FHTX)
Gatos Silver, Inc. (GATO)
Priced IPO
Opthea Limited (OPT)
Eargo, Inc. (EAR)
Aligos Therapeutics, Inc (ALGS)
Praxis Precision Medicines, Inc. (PRAX)
Tarsus Pharmaceuticals, Inc. (TARS)
Array Technologies, Inc. (ARRY)
MINISO Group Holding Limited (MNSO)
Codiak BioSciences, Inc. (CDAK)
Intrusion Securties Inc. (INTZ)
iHuman Inc. (IH)
Shattuck Labs, Inc. (STTK)
Kronos Bio, Inc. (KRON)
Spruce Biosciences, Inc. (SPRB)
Aziyo Biologics, Inc. (AZYO)
fuboTV Inc. (FUBO)
Presidio Property Trust (SQFT)
Academy Sports and Outdoors, Inc. (ASO)
Immunome Inc. (IMNM)
C4 Therapeutics, Inc. (CCCC)
Oncorus, Inc (ONCR)
More companies

Eargo, Inc. (EAR)

Sector - Healthcare

Price chart

Company News

IPO Profile

About company

They are a medical device company dedicated to improving the quality of life of people with hearing loss. They developed the Eargo solution to create a hearing aid that consumers actually want to use. Their innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. They believe their Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regulated, exempt Class I device for the treatment of hearing loss. Their rapid pace of innovation is enabled by their deep industry and technical expertise across mechanical engineering, product design, audio processing, clinical and hearing science, consumer electronics and embedded software design, and is supported by their strategic intellectual property portfolio. Their differentiated, consumer-first approach empowers consumers to take control of their hearing by improving accessibility, with personalized, high-quality hearing support from licensed hearing professionals. They believe that their differentiated hearing aids, consumer-oriented approach and strong brand have fueled the rapid adoption of their products and high customer satisfaction, as evidenced by over 42,000 Eargo hearing aid systems sold, net of returns, as of June 30, 2020. They believe this represents the beginning of their penetration into a large, growing and underserved market of people with hearing loss, which they estimate included approximately 43 million adults in the United States and more than 465 million adults globally in 2019.
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CEO CFO
Christian Gormsen Adam Laponis
Employees Founded
184 2010

Contacts

Address: 1600 Technology Drive, 6th Floor San Jose, California 95110

Telephone: (650) 351-7700

Web page: http://www.eargo.com

IPO information

Expected Date 10/16/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Financial Data (last reporting year)

Market Cap (MM) $526.5
Revenues (MM) $46.9
Net Income (Loss) (MM) $-43.9

Voting

What do you think will happen with the EAR share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Shares Initial (MM) 6.7
Shares Revised (MM) 7.8
Expected offer amount (MM) $100.5
Realized offer amount(MM) $140.4
Underwriters
JP Morgan/ BofA Securities
CO-Managers
Wells Fargo/ William Blair

Sector: Healthcare

Tweets about $EAR

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats